Wells Fargo keeps Bath & Body Works at Overweight and lifts its target to $25
Wells Fargo retained its Overweight rating on Bath & Body Works and raised its price target to $25 from $24, according to TradingView citing Benzinga.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Wells Fargo kept its Overweight rating on Bath & Body Works shares and raised its price target by 4.2%, to $25 from $24. According to TradingView, citing Benzinga, the new target implies roughly 15.5% upside from the October 28 close of $21.64.
Dow Jones Newswires reported the same revision, noting the increase from $24 to $25 per share. The full history of analyst ratings for the company is available through Benzinga's data.
why it matters
The story concerns a single company and a routine analyst update, so its reach beyond this stock is limited. For investors in the retail sector, such revisions show how professional analysts view the company's outlook, but on their own they rarely move shares for long. An analyst's target is not a forecast and does not replace independent research.
tags
instruments
sources
- Wells Fargo maintains Bath & Body Works at Overweight, raises price target to $25 from $24 — TradingView, 29 October 2026 at 13:28 UTC
- Bath & Body Works Is Maintained at Overweight by Wells Fargo — Dow Jones Newswires, 29 October 2026 at 13:39 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗